ARGX Argenx: Earnings per share for the last twelve months

Official company branding of argenx SE (ARGX)

The growth of the Vyvgart patient base and the expansion of indications drive the price action for argenx SE (ARGX), despite pricing pressure from regulators. Revenues are based on the sale of unique antibodies for neurology, while competent management has ensured trial transparency and the successful launch of blockbusters. The rolling net income per share smooths out market noise, while 26.06 reflects the latest value of the metric.

argenx SE (ARGX) - Net earnings per share (EPS TTM) from 07/04/2022 to 11/15/2026

Analytical breakdowns and data insights for company Argenx (ARGX)

- current quotes and average value forecast:
Price Chart argenx N.V.|ARGX - Consensus Target
- company stock capitalization data:
Market Value argenx BVBA|ARGX - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value per Share argenx|ARGX - Book Capitalization|Market Value to Book Value Ratio argenx.com|ARGX - Total Business Assets
- debt and liquidity data:
Total Debt to Capital argenx SE|ARGX - Long-Term Liabilities to Capital|Short-Term Debt to Capital argenx BVBA|ARGX - Company Aggregate Debts|Debt to Book Capitalization Ratio argenx BVBA|ARGX - Company Long-Term Loans and Borrowings|Company Short-Term Debts argenx|Quick Ratio argenx.com
- earnings and valuation multiples indicators:
ARGX - Company Net Income|Expected Profit argenx SE|ARGX - Price to Earnings Multiple|Projected Price to Earnings argenx SE|ARGX - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio argenx BVBA|ARGX - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months argenx|ARGX - Net earnings per share for the last four quarters|Quarterly EPS earnings growth argenx.com|ARGX - Earnings per share growth rate in current year|Earnings growth forecast for next year argenx SE
- sales and revenue data:
ARGX - Revenue and Sales Volume|Company Projected Revenue argenx|ARGX - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Argenx|ARGX - Revenue Growth Rate YoY (Last Twelve Months)
Analysis of all company metrics:ARGX - argenx
Manufactured products of argenx N.V.

Investors utilize this criterion to assess the real yield of each share, excluding the impact of issuances or share buybacks on the final financial result. The rolling year net income per share reflects the efficiency of argenx SE's transformation from a startup into a commercial leader, confirming management's financial discipline through the growth trend of actual earnings per share.

Competing companies

BNTX - Earnings per share for the last twelve months|Abivax Corp (ABVX) - Net earnings per share for the last 12 months|ADMA Corp (ADMA) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Protagonist Therapeutics|Net earnings per share for the last 12 months IMVT|Net earnings per share (EPS TTM) kiniksa.com|Earnings per share for the last twelve months Grifols Group (GRFS)|Adaptive Biotechnologies Corporation - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) CLDX (celldex.com)|Aurinia Pharma (AUPH) - Net earnings per one share for the last twelve months|BioCryst - Net earnings per share (EPS TTM)|VERA: Earnings per share for the last twelve months|DNTH: Net earnings per share (EPS TTM)|Pharvaris - Earnings per share for the trailing year|ABCL (AbCellera Bio) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Tourmaline|Net earnings per share (EPS TTM) PGEN|PHAR (pharming.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NKTR (nektar.com)|Upstream Bio (UPB) - Net earnings per one share for the last twelve months|ZBIO: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Immunome Bio|GOSS: Net earnings per share (EPS TTM)|KALV: Earnings per share for the last four quarters|SEPN (septerna.com) - Net earnings per share (EPS TTM)|Pieris Pharmaceuticals, Inc. - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Savara Inc. (SVRA)|Net earnings per share (EPS TTM) Rigel Corp (RIGL)|Earnings per share for the last twelve months AnaptysBio Inc ANAB|astriatx.com (ATXS) - Net earnings per one share for the last twelve months|enGene Bio - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months RAPT|JBIO: Net earnings per share (EPS TTM)|Aclaris - Earnings per share for the trailing year|KYTX (Kyverna Therapeutics, Inc) - Net earnings per share (EPS TTM)|TLSA: Earnings per share for the trailing year|Net earnings per share for the last 12 months CABA (Cabaletta Bio)|VTYX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) THTX (Theratechnologies, Inc)|Earnings per share for the last four quarters AVTX (Avalo Therapeutics Inc.)|ELDN: Net earnings per share for the last 12 months|AGEN - Net earnings per share (EPS TTM)|Climb Bio Inc. (CLYM) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ZURA (Zura Bio)|Net earnings per share for the last 12 months ATYR|ADAG: Earnings per share for the trailing year|Net earnings per share (EPS TTM) IMA|Net earnings per share for the last four quarters Shattuck Therapeutics|Net earnings per share (EPS TTM) EQ (Equillium Inc)|Earnings per share for the last four quarters CNTB (Connect Pharma)|IMUX - Earnings per share for the last twelve months|Net earnings per share for the last four quarters atarabio.com ATRA|IFRX: Net earnings per share (EPS TTM)|XFOR (X4 Pharmaceuticals, Inc) - Earnings per share for the last twelve months|Earnings per share for the last twelve months adicetbio.com|CELU: Earnings per share for the trailing year|Earnings per share for the last twelve months INmune Bio Corporation (INMB)|Net earnings per share for the last 12 months Barinthus Biotherapeutics Corp BRNS|Earnings per share for the last twelve months Kezar Life Sciences KZR|Earnings per share for the trailing year SABS|AKTX - Earnings per share for the last twelve months|Earnings per share for the trailing year ENLV (enlivex.com)|Q32 Bio Inc. (QTTB) - Earnings per share for the last twelve months|GeoVax Labs Inc - Earnings per share for the trailing year|EDSA (Edesa Biotech Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months IBIO|Earnings per share for the last twelve months Carisma Therapeutics Inc (CARM)|Net earnings per share (EPS TTM) XTL Biopharmaceuticals Ltd (XTLB)|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics Inc.)|Net earnings per share for the last four quarters HCW Biologics Inc. (HCWB)|Aptevo Therapeutics, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters aimimmuno.com AIM|ADTX (aditxt.com) - Net earnings per share for the last 12 months|GRI (GRI Bio) - Earnings per share for the last twelve months|XRTX (XORTX Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Vyome Therapeutics|Net earnings per share (EPS TTM) REVB|Net earnings per share for the last 12 months indaptusrx.com INDP|Net earnings per share (EPS TTM) SCNI (scinai.com)|Net earnings per share (EPS TTM) CalciMedica, Inc. CALI|AFMD - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Allakos Inc ALLK|HOOK: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months IGM Biosciences Inc. (IGMS)|ITOS (iTeos Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ocean Biomedical Inc OCEA|Earnings per share for the last twelve months TC BioPharm Ltd (TCBP)|THRD (Third Harmonic Bio, Inc) - Earnings per share for the trailing year